Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NDUFS8 | O00217 | 2/20 | 0.43 |
| ▸ | COXFA4 | O00483 | 2/20 | 0.43 |
| ▸ | NDUFAB1 | O14561 | 2/20 | 0.43 |
| ▸ | NDUFA1 | O15239 | 2/20 | 0.43 |
| ▸ | NDUFS4 | O43181 | 2/20 | 0.43 |
| ▸ | NDUFB5 | O43674 | 2/20 | 0.43 |
| ▸ | NDUFB3 | O43676 | 2/20 | 0.43 |
| ▸ | NDUFC1 | O43677 | 2/20 | 0.43 |
| ▸ | NDUFA2 | O43678 | 2/20 | 0.43 |
| ▸ | NDUFS5 | O43920 | 2/20 | 0.43 |
| ▸ | NDUFS7 | O75251 | 2/20 | 0.43 |
| ▸ | NDUFS2 | O75306 | 2/20 | 0.43 |
| ▸ | NDUFS6 | O75380 | 2/20 | 0.43 |
| ▸ | NDUFB1 | O75438 | 2/20 | 0.43 |
| ▸ | NDUFS3 | O75489 | 2/20 | 0.43 |
| ▸ | NDUFB6 | O95139 | 2/20 | 0.43 |
| ▸ | NDUFA3 | O95167 | 2/20 | 0.43 |
| ▸ | NDUFB4 | O95168 | 2/20 | 0.43 |
| ▸ | NDUFB8 | O95169 | 2/20 | 0.43 |
| ▸ | NDUFB2 | O95178 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10336303 | 0.74 | HTT (0.48) | CYP3A4KDM4EALDH1A1HSD17B10HPGD | |
| SCHEMBL8897227 | 0.73 | MAOA (0.50) | CYP3A4KDM4EHSD17B10CYP2D6CYP2C9 | |
| SCHEMBL1713988 | 0.73 | HTT (0.42) | NDUFS8COXFA4NDUFAB1NDUFA1NDUFS4 | |
| SCHEMBL7754898 | 0.73 | HTT (0.53) | CYP3A4KDM4EALDH1A1HSD17B10HPGD | |
| SCHEMBL1301705 | 0.71 | CYP3A4 (0.62) | CYP3A4TDP1KDM4EALDH1A1HSD17B10 | |
| SCHEMBL3447032 | 0.70 | MAOA (0.47) | CYP3A4KDM4EHSD17B10CYP2D6CYP2C9 | |
| SCHEMBL7877813 | 0.68 | SIGMAR1 (0.49) | CYP3A4TDP1KDM4EALDH1A1HSD17B10 | |
| SCHEMBL14152660 | 0.68 | KCNA3 (0.51) | CYP3A4KDM4EHSD17B10CYP2D6CYP2C9 | |
| SCHEMBL29419951 | 0.67 | NDUFS8 (0.70) | NDUFS8COXFA4NDUFAB1NDUFA1NDUFS4 | |
| SCHEMBL8936325 | 0.65 | MAOA (0.56) | ALOX15CYP3A4KDM4EALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114166961-B | Method for measuring phenolic compounds in citrus juice product and pretreatment method thereof | 西南大学 | 2022-11-22 | — | — | CN | claimed |
| JP-7025764-A | — | — | None | — | — | JP | disclosed |
| US-20250032448-A1 | COMPOUND FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES | KOH, Hwee Ling (SG) | 2025-01-30 | — | — | US | disclosed |
| US-12144797-B2 | Compound for use in the treatment and/or prevention of parasitic mediated diseases | KOH, Hwee Ling (SG) | 2024-11-19 | — | — | US | disclosed |
| CN-111133087-A | Cold treatment | 西姆莱斯股份公司 | 2020-05-08 | — | — | CN | disclosed |
| EP-3389649-A1 | COMPOUND FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES | Leeward Pacific Pte Ltd (SG) | 2018-10-24 | — | — | EP | disclosed |
| WO-2017155465-A1 | COMPOUND FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES | LEEWARD PACIFIC PTE LTD (SG) | 2017-09-14 | — | — | WO | disclosed |
| JP-H0725764-A | ANTIBACTERIAL AGENT | POKKA CORP | 1995-01-27 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12144797-B2 | Compound for use in the treatment and/or prevention of parasitic mediated diseases | ICMT, ALG3, PFN1 | NDUFS8 1393/4885COXFA4 2294/4885NDUFAB1 2561/4885 |
| US-20250032448-A1 | COMPOUND FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES | EPX, PKD2, MPO | NDUFS8 1837/4885COXFA4 2828/4885NDUFAB1 2489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.